Case Study 1: Normal Cognition

Liz, age 58, is a self-proclaimed anti-aging warrior who is passionate about researching anti-aging medical options. At a recent medical appointment, Liz expressed her concerns about brain fog, which she admits is most likely due to hormonal changes and environmental stressors. Seeking answers, Liz decided to participate in a clinical trial focused on investigating amyloid in the brains of cognitively healthy people.

The clinical trial was prematurely terminated due to production issues with the radiotracer. The participants were initially not informed of the results. Liz has since learned that her amyloid positron emission tomography (PET) scan was positive.

Liz’s maternal grandmother was diagnosed with dementia, and Liz has become increasingly concerned about her own risk of developing Alzheimer’s disease (AD). She requests a "full workup" to assess her overall risk and explore potential preventative options. Liz has no biological children and is concerned about who will care for her if she develops AD later in life.